Elevated circulating lipasin/betatrophin in human type 2 diabetes and obesity
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Lipasin (also known as C19ORF80, RIFL, ANGPTL8 and betatrophin) is a newly discovered circulating factor that regulates lipid metabolism and promotes pancreatic β-cell proliferation. Whether circulating levels of lipasin in humans are altered in a) type 2 diabetes; b) obesity and c) the postprandial state, however, is unknown. The current study aimed to compare serum lipasin levels in those who were a) non-diabetic (N=15) or diabetic (BMI- and age-matched; N=14); b) lean or obese (N=53 totally) and c) fasting and 2 hours following a defined meal (N=12). Serum lipasin levels were determined by the enzyme-linked immunosorbent assay. Lipasin levels [mean±SEM] were increased by more than two fold (P<0.001) in the diabetic patients (5.56±0.73 ng/mL) as compared to the control subjects (2.19±0.24 ng/mL). Serum lipasin levels were positively correlated with BMI (rho=0.49, P<0.001), and showed a 35% increase 2 hours following a defined meal (P=0.009). Therefore, lipasin/betatrophin is nutritionally-regulated hepatokine that is increased in human type 2 diabetes and obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“This is substantiated by the fact that betatrophin levels are higher in T2DM patients,182, 183, 184 although they were lower in one study.185”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [184]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Betatrophin: A Hormone that Controls Pancreatic β Cell Proliferation
Yi, P., Park, J.-S., & Melton, D. A. (2013) · Cell · doi:10.1016/j.cell.2013.04.008 · Cited by 449
RetractedEckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Eckel, R. H., Grundy, S. M., & Zimmet, P. Z. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,550
Biological, clinical and population relevance of 95 loci for blood lipids
Teslovich, T. M., Musunuru, K., Smith, A. V., Edmondson, A. C., Stylianou, I. M., Koseki, M., Pirruccello, J. P., Ripatti, S., Chasman, D. I., Willer, C. J., et al. (2010) · Nature · doi:10.1038/nature09270 · Cited by 3,487
Obesity and Diabetes in the Developing World — A Growing Challenge
Hossain, P., Kawar, B., & El Nahas, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmp068177 · Cited by 2,200
Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871
Grundy, S. M. (2011) · Atlas of Atherosclerosis and Metabolic Syndrome · doi:10.1007/978-1-4419-5839-6_1 · Cited by 1,223
Selective versus Total Insulin Resistance: A Pathogenic Paradox
Brown, M. S., & Goldstein, J. L. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.12.009 · Cited by 965
Uyeda, K., & Repa, J. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.06.008 · Cited by 529
Biddinger, S. B., Hernandez-Ono, A., Rask-Madsen, C., Haas, J. T., Alemán, J. O., Suzuki, R., Scapa, E. F., Agarwal, C., Carey, M. C., Stephanopoulos, G., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.013 · Cited by 469
Cited by
Pancreatic regulation of glucose homeostasis.
Röder, P. V., Wu, B., Liu, Y., & Han, W. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.6 · Cited by 985
Fructose metabolism and metabolic disease
Hannou, S. A., Haslam, D. E., McKeown, N. M., & Herman, M. A. (2018) · Journal of Clinical Investigation · doi:10.1172/jci96702 · Cited by 561
Molecular aspects of fructose metabolism and metabolic disease
Herman, M. A., & Birnbaum, M. J. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.09.010 · Cited by 290
Atkinson, E. G., Maihofer, A. X., Kanai, M., Martin, A. R., Karczewski, K. J., Santoro, M. L., Ulirsch, J. C., Kamatani, Y., Okada, Y., Finucane, H. K., et al. (2021) · Nature Genetics · doi:10.1038/s41588-020-00766-y · Cited by 240
“This approach provides a number of benefits over traditional GWAS, including the production of accurate ancestry-specific summary statistics, improved localization of GWAS signals, and power boosts in many genetic contexts.”
Diabetes mellitus in patients with cirrhosis: clinical implications and management
Elkrief, L., Rautou, P., Sarin, S., Valla, D., Paradis, V., & Moreau, R. (2016) · Liver International · doi:10.1111/liv.13115 · Cited by 220
The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking
Zhang, R. (2016) · Open Biology · doi:10.1098/rsob.150272 · Cited by 219
Self-citationANGPTL8/Betatrophin Does Not Control Pancreatic Beta Cell Expansion
Gusarova, V., Alexa, C. A., Na, E., Stevis, P. E., Xin, Y., Bonner-Weir, S., Cohen, J. C., Hobbs, H. H., Murphy, A. J., Yancopoulos, G. D., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.027 · Cited by 202
“ANGPTL8 levels were found in one study to correlate with type 2 diabetes and body mass index (Fu et al., 2014), whereas another”
Regulation of lipid metabolism by angiopoietin-like proteins
Dijk, W., & Kersten, S. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000290 · Cited by 192
Circulating Betatrophin Concentrations Are Decreased in Human Obesity and Type 2 Diabetes
Gómez-Ambrosi, J., Pascual, E., Catalán, V., Rodríguez, A., Ramírez, B., Silva, C., Gil, M. J., Salvador, J., & Frühbeck, G. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1568 · Cited by 183
“obesity and T2D (18), in contrast to our results.”
ResultIizuka, K., Takao, K., & Yabe, D. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.587189 · Cited by 175
Chen, X., Lu, P., He, W., Zhang, J., Liu, L., Yang, Y., Liu, Z., Xie, J., Shao, S., Du, T., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2300 · Cited by 129
Abu-Farha, M., Abubaker, J., Al-Khairi, I., Cherian, P., Noronha, F., Hu, F. B., Behbehani, K., & Elkum, N. (2015) · Scientific Reports · doi:10.1038/srep10949 · Cited by 126
Lee, Y., Lee, S., Lee, C. J., Kim, S. H., Song, Y.-M., Yoon, M. R., Jeon, B. H., Lee, J. H., Lee, B., Kang, E. S., et al. (2016) · Scientific Reports · doi:10.1038/srep24013 · Cited by 120
Zhang, R., & Abou-Samra, A. B. (2014) · Cardiovascular Diabetology · doi:10.1186/preaccept-6310273751364807 · Cited by 108
“The first controversy is that many different names have been proposed for this protein, including RIFL [15], lipasin [16-18], Angptl8 [19,20], betatrophin [21-24] and C19orf80 [25].”
BackgroundInfluentialSelf-citationZhang, Y., Guo, X., Yan, W., Chen, Y., Ke, M., Cheng, C., Zhu, X., Xue, W., Zhou, Q., Zheng, L., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02355-w · Cited by 108
Zhang, Z., Yuan, Y., Hu, L., Tang, J., Meng, Z., Dai, L., Gao, Y., Ma, S., Wang, X., Yuan, Y., et al. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2022.08.006 · Cited by 102
“ANGPTL8, also known as Lipasin, RIFL, or TD26 [9,10,11], is a secretory protein that is highly expressed in the liver, during eating but expressed at low levels during fasting periods [9,12].”
BackgroundCirculating betatrophin is elevated in patients with type 1 and type 2 diabetes
Yamada, H., Saito, T., Aoki, A., Asano, T., Yoshida, M., Ikoma, A., Kusaka, I., Toyoshima, H., Kakei, M., & Ishikawa, S. (2015) · Endocrine Journal · doi:10.1507/endocrj.ej14-0525 · Cited by 96
“found that serum levels of lipasin/betatrophin were increased in overweight and obese subjects, and suggested that the conflicting results may be due to differences between ELISA/EIA kits with reactivity to the C- or N-terminus of betatrophin [13].”
BackgroundResultAbu‐Farha, M., Ghosh, A., Al‐Khairi, I., Madiraju, S. R. M., Abubaker, J. A., & Prentki, M. (2020) · Progress in Lipid Research · doi:10.1016/j.plipres.2020.101067 · Cited by 97
Zhang, R., & Zhang, K. (2022) · Progress in Lipid Research · doi:10.1016/j.plipres.2021.101140 · Cited by 90
Self-citationAn explanation for recent discrepancies in levels of human circulating betatrophin
Fu, Z., Abou‐Samra, A., & Zhang, R. (2014) · Diabetologia · doi:10.1007/s00125-014-3346-1 · Cited by 89
“Interestingly, results based on both the N- [8] and the C-terminal kits [9] have consistently suggested increased circulating betatrophin in type 2 diabetes, in which, therefore, both full-length and total betatrophin levels are likely elevated.”
BackgroundMethodSelf-citationCirculating ANGPTL8/Betatrophin Is Increased in Obesity and Reduced after Exercise Training
Abu-Farha, M., Sriraman, D., Cherian, P., AlKhairi, I., Elkum, N., Behbehani, K., & Abubaker, J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0147367 · Cited by 86
“Obesity has also been shown to increase the level of ANGPTL8 by some studies [21] while others showed a decrease [24].”
BackgroundInfluentialRegulation of Angiopoietin-Like Proteins (ANGPTLs) 3 and 8 by Insulin
Nidhina Haridas, P. A., Soronen, J., Sädevirta, S., Mysore, R., Quagliarini, F., Pasternack, A., Metso, J., Perttilä, J., Leivonen, M., Smas, C. M., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1254 · Cited by 75
“gested eg, in obesity either increased (36), unchanged (18)”
BackgroundIizuka, K. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.11.029 · Cited by 89
“Moreover, plasma levels of glucose are positively correlated with Angtl8 mRNA levels [136].”
BackgroundANGPTL8: An Important Regulator in Metabolic Disorders
Luo, M., & Peng, D. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00169 · Cited by 83
“Alterations in ANGPTL8 level were found in subjects with obesity (22, 36, 38, 40, 42, 43), but the pattern of alteration was controversial (Table 2).”
BackgroundFu, Z., Abou-Samra, A. B., & Zhang, R. (2015) · Scientific Reports · doi:10.1038/srep18502 · Cited by 82
Self-citationCirculating angiopoietin-like protein 8 (betatrophin) association with HsCRP and metabolic syndrome
Abu‐Farha, M., Abubaker, J. A., Al‐Khairi, I., Cherian, P., Noronha, F., Kavalakatt, S., Khadir, A., Behbehani, K., Alarouj, M., Bennakhi, A., et al. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0346-0 · Cited by 78
“Our current data is in line with what has been reported about the increased ANGPTL8 level in obesity and T2D [21, 31–34].”
ResultVatner, D. F., Goedeke, L., Camporez, J.-P. G., Lyu, K., Nasiri, A. R., Zhang, D., Bhanot, S., Murray, S. F., Still, C. D., Gerhard, G. S., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4579-1 · Cited by 76
“Prior studies of ANGPTL8 in human blood reported increases in circulating ANGPTL8 in individuals with the metabolic syndrome [43] and type 2 diabetes [44, 45]; furthermore, serum ANGPTL8 levels correlate with BMI [45] and hepatic steatosis [46].”
BackgroundGuo, K., Lu, J., Yu, H., Zhao, F., Pan, P., Zhang, L., Chen, H., Bao, Y., & Jia, W. (2015) · Obesity · doi:10.1002/oby.21038 · Cited by 75
“For instance, levels of fasting betatrophin were either unaltered (7), decreased (10), or increased in T2DM (8).”
BackgroundAngptl8 mediates food-driven resetting of hepatic circadian clock in mice
Chen, S., Feng, M., Zhang, S., Dong, Z., Wang, Y., Zhang, W., & Liu, C. (2019) · Nature Communications · doi:10.1038/s41467-019-11513-1 · Cited by 79
ANGPTL8 (betatrophin) role in diabetes and metabolic diseases
Abu‐Farha, M., Abubaker, J. A., & Tuomilehto, J. O. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2919 · Cited by 72
“24 lean vs 29 overweight and obese people.(37) Phoenix Pharmaceuticals ELIS kit.”
BackgroundResultInfluentialEbert, T., Kralisch, S., Wurst, U., Lössner, U., Kratzsch, J., Blüher, M., Stümvoll, M., Tönjes, A., & Faßhauer, M. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0815 · Cited by 69
Emerging Regulation and Function of Betatrophin
Tseng, Y., Yeh, Y., Chen, W.-J., & Lin, K. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151223640 · Cited by 71
Guo, X., Wang, X. L., Chen, Y., Yuan, Y., Chen, Y. M., Ding, Y., Fang, J., Bian, L. J., & Li, D. S. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.09.012 · Cited by 68
Increased levels of irisin in people with long‐standing Type 1 diabetes
Espes, D., Lau, J., & Carlsson, P. (2015) · Diabetic Medicine · doi:10.1111/dme.12731 · Cited by 67
Morelli, M. B., Chavez, C., & Santulli, G. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1707806 · Cited by 67
“involved in energy homeostasis, recognizes ChRE element and plays a significant role in both glucose and lipid metabolism [92].”
BackgroundLee, J., Hong, S., Park, S. E., Rhee, E., Park, C., Oh, K.-W., Park, S., & Lee, W. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.07.031 · Cited by 66
“Circulating ANGPTL8 levels are closely associated with glucose levels in patients with type 2 diabetes and a binding site for ChREBP has been identified in the promoter sequence of ANGPTL8 (Fu et al., 2014).”
BackgroundChen, C.-C., Susanto, H., Chuang, W.-H., Liu, T.-Y., & Wang, C.-H. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0326-9 · Cited by 59
“[10], and a number of studies showed that betatrophin upregulated in T2DM patients [12, 18, 19], while Gomez-Ambrosi et al.”
BackgroundResultInfluentialGao, T., Jin, K., Chen, P., Jin, H., Yang, L., Xie, X., Yang, M., Hu, C., & Yu, X. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133640 · Cited by 54
Crujeiras, A. B., Zulet, M. Á., Abete, I., Amil, M., Carreira, M. C., Martínez, J. A., & Casanueva, F. F. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.206 · Cited by 51
A unified model for regulating lipoprotein lipase activity
Zhang, R., & Zhang, K. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.02.016 · Cited by 56
Self-citationWang, H., Lai, Y., Han, C., Liu, A., Fan, C., Wang, H., Zhang, H., Ding, S., Teng, W., & Shan, Z. (2016) · Scientific Reports · doi:10.1038/srep28431 · Cited by 50
Circulating Betatrophin Levels Are Increased in Anorexia and Decreased in Morbidly Obese Women
Barja-Fernández, S., Folgueira, C., Seoane, L. M., Casanueva, F. F., Diéguez, C., Castelao, C., Agüera, Z., Baños, R., Botella, C., de la Torre, R., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1595 · Cited by 51
“The fact that betatrophin is nutritionally regulated (21) also suggests that the time under fasting before blood extraction or even the nutritional composition of meals might play an important role in the regulation of this hormone.”
BackgroundResultInfluentialGómez‐Ambrosi, J., Corrales, E. P., Catalán, V., Rodríguez, A., Ramírez, B., Romero, S., Vila, N., Ibáñez, P., Margall, M. A., Silva, C., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2084 · Cited by 48
Xu, Q., Zhang, J., Lu, Y., & Wu, L. Y. (2024) · iScience · doi:10.1016/j.isci.2024.108783 · Cited by 50
“53,54 Over-expression of ANGPTL8 inhibits triglyceride clearance and leads to higher serum triglyceride levels and liver fat accumulation, whereas ablation of ANGPTL8 reduces plasma triglyceride concentrations in a rat model.”
BackgroundInsulin upregulates betatrophin expression via PI3K/Akt pathway
Lu, P., Chen, X., Zhang, Z., Zhang, J., Yang, Y., Liu, Z., Xie, J., Shao, S., Zhou, X., Hu, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06052-y · Cited by 41
iRhom2 deficiency relieves TNF-α associated hepatic dyslipidemia in long-term PM2.5-exposed mice
Ge, C., Qin, Y., Lou, D., Li, Q., Li, Y., Wang, Z.-M., Yang, W., Wang, M., Liu, N., Wang, Z., et al. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.09.152 · Cited by 43
Wu, S., Gao, H., Ma, Y., Fu, L., Zhang, C., & Luo, X. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12233 · Cited by 42
“Two subsequent independent studies demonstrated that betatrophin concentrations were higher in adults with T2DM than in those with non-diabetic obesity (15, 18).”
BackgroundResultInfluentialEvaluation of circulating betatrophin levels in gestational diabetes mellitus
Erol, O. Ö., Ellidağ, H. Y., Ayık, H., Özel, M. K., Derbent, A. U., & Yılmaz, N. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1056142 · Cited by 41
“[16] reported markedly increased serum betatrophin levels in type 2 DM and in overweight/obese patients compared to non-diabetic and lean control subjects.”
BackgroundAssociations of betatrophin levels with irisin in Chinese women with normal glucose tolerance
Xie, X., Gao, T., Yang, M., Chen, P., Jin, H., Yang, L., & Yu, X. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0019-2 · Cited by 41
ChREBP Reciprocally Regulates Liver and Plasma Triacylglycerol Levels in Different Manners
Iizuka, K., Takao, K., Kato, T., Horikawa, Y., & Takeda, J. (2018) · Nutrients · doi:10.3390/nu10111699 · Cited by 43
“Angptl8 is known to increase plasma TAG levels by suppressing lipoprotein lipase [21] and Angptl8 is a target gene for ChREBP [45].”
BackgroundLack of associations between betatrophin/ANGPTL8 level and C-peptide in type 2 diabetic subjects
Abu‐Farha, M., Abubaker, J. A., Noronha, F., Al‐Khairi, I., Cherian, P., Alarouj, M., Bennakhi, A., & Elkum, N. B. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0277-1 · Cited by 40
“Betatrophin concentration was determined using ELISA (Wuhan EIAAB) as reported previously [24, 36, 37].”
MethodCirculating Betatrophin in Patients with Type 2 Diabetes: A Meta-Analysis
Li, S., Liu, D., Li, L., Li, Y., Li, Q., An, Z., Sun, X., & Tian, H. (2015) · Journal of Diabetes Research · doi:10.1155/2016/6194750 · Cited by 40
“As shown in Figure 3, three comparisons in two studies [11, 12] detected total betatrophin and indicated that the total circulating betatrophin in T2DM patients was higher than that in the nondiabetic controls (SMD, 0.”
BackgroundMethodResultInfluentialIncreased Maternal and Cord Blood Betatrophin in Gestational Diabetes
Wawrusiewicz‐Kurylonek, N., Telejko, B., Kuźmicki, M., Sobota, A., Lipińska, D., Pliszka, J., Raczkowska, B. A., Kuć, P., Urban, R., Szamatowicz, J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131171 · Cited by 40
“Experimental studies have shown that betatrophin expression is suppressed by starving [2, 3] and induced by food intake [2, 3, 9], insulin [4] and an exposure to a cold environment [1].”
BackgroundSiddiqa, A., Cirillo, E., Tareen, S. H. K., Ali, A., Kutmon, M., Eijssen, L., Ahmad, J., Evelo, C. T., & Coort, S. L. (2017) · Genomics · doi:10.1016/j.ygeno.2017.06.006 · Cited by 38
“Increased serum ANGPTL8 has also been observed in several diseases including DM, MetS and NAFLD (Non-alcoholic fatty liver disease ) [9, 10, 11, 12].”
BackgroundInfluentialIzumi, R., Kusakabe, T., Noguchi, M., Iwakura, H., Tanaka, T., Miyazawa, T., Aotani, D., Hosoda, K., Kangawa, K., & Nakao, K. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m082099 · Cited by 37
Uchiyama, T., Ota, H., Itaya‐Hironaka, A., Shobatake, R., Yamauchi, A., Sakuramoto‐Tsuchida, S., Makino, M., Kimura, H., Takeda, M., Ohbayashi, C., et al. (2017) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2017.07.005 · Cited by 42
von Loeffelholz, C., Pfeiffer, A. F. H., Lock, J. F., Lieske, S., Döcke, S., Murahovschi, V., Kriebel, J., Gala, T. D. L. H., Grallert, H., Rudovich, N. N., et al. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-102950 · Cited by 34
“This could be of interest since ANGPTL8/betatrophin is known to be nutritionally regulated [4, 21, 22] whereby our intervention supports the impact of dietary manipulation also in the long term.”
BackgroundResultMartinez-Perez, B., Ejarque, M., Gutiérrez, C., Núñez‐Roa, C., Roche, K., Vila‐Bedmar, R., Ballesteros, M., Redondo‐Angulo, I., Planavila, A., Villarroya, F., et al. (2016) · Translational research · doi:10.1016/j.trsl.2016.06.012 · Cited by 34
Fu, J., Hou, C., Li, L., Feng, D., Li, G., Li, M., Li, C., Gao, S., & Li, M. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0461-y · Cited by 34
“For instance, betatrophin levels were variable in type 2 diabetes mellitus (T2DM), either increased [11–14, 23] or decreased [15, 22], and similar patterns were observed in obesity [13, 15, 17–20] and IR [10–12, 15, 21, 22].”
BackgroundResultInfluentialLópez-Bermudo, L., Luque‐Sierra, A., Maya‐Miles, D., Gallego‐Durán, R., Ampuero, J., Romero‐Gómez, M., Berná, G., & Martín, F. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.892672 · Cited by 37
“Recently, several human studies have shown that serum ANGPTL8 levels are increased in patients with obesity (11), T2D (11) and NAFLD (12).”
BackgroundRelationship of betatrophin with youth onset type 2 diabetes among Asian Indians
Gokulakrishnan, K., Manokaran, K., Pandey, G. K., Amutha, A., Ranjani, H., Anjana, R. M., & Mohan, V. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.04.028 · Cited by 32
“atherogenic lipid profile in high-risk cohorts with morbid obesity or T2DM [9,10].”
BackgroundYi, M., Chen, R., Yang, R., Guo, X., Zhang, J.-C., & Chen, H. (2015) · International Journal of Endocrinology · doi:10.1155/2015/479157 · Cited by 38
Tuhan, H., Abacı, A., Anık, A., Çatlı, G., Küme, T., Çalan, Ö. G., Acar, S., & Böber, E. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.02.008 · Cited by 31
“Despite elevated betatrophin levels inseveral studies [7,10,12], this study demonstrated that serum betatrophin levels were lower in obese children than in the non-obese children.”
BackgroundResultInfluentialCirculating Betatrophin Is Increased in Patients with Overt and Subclinical Hypothyroidism
Han, C., Xia, X., Liu, A., Zhang, X., Zhou, M., Xiong, C., Liu, X., Sun, J., Shi, X., Shan, Z., et al. (2016) · BioMed Research International · doi:10.1155/2016/5090852 · Cited by 32
“There were no significant differences in age, sex, BMI, diastolic blood pressure (DBP), systolic blood pressure (SBP), HDL-C, TC, and liver function among the groups (all𝑃 values> 0.05).”
BackgroundInfluentialANGPTL8 in metabolic homeostasis: more friend than foe?
Guo, C. Y., Wang, C., Deng, X., He, J., Yang, L., & Yuan, G. (2021) · Open Biology · doi:10.1098/rsob.210106 · Cited by 31
“The binding site of carbon responsive element binding protein (ChREBP) was found in the promoter sequence of ANGPTL8, which provides a more specific mechanism for LXR to participate in the regulation of ANGPTL8 expression [25].”
BackgroundInfluentialIncreased Serum ANGPTL8 Concentrations in Patients with Prediabetes and Type 2 Diabetes
Yin, Y., Ding, X., Peng, L., Hou, Y., Ling, Y., Gu, M., Wang, Y., Peng, Y., & Sun, H. (2017) · Journal of Diabetes Research · doi:10.1155/2017/8293207 · Cited by 31
“described was the differences in ANGPTL8 antibodies, being against the N-terminus or the C-terminus, in ELISA kits used in different studies [16].”
MicroRNA-221-3p Regulates Angiopoietin-Like 8 (ANGPTL8) Expression in Adipocytes
Mysore, R., Ortega, F. J., Latorre, J., Ahonen, M. A., Savolainen-Peltonen, H. M., Fischer‐Posovszky, P., Wabitsch, M., Olkkonen, V. M., Fernández‐Real, J. M., & Haridas, P. A. N. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00453 · Cited by 29
Hong, B. S., Liu, J., Zheng, J., Ke, W., Huang, Z., Wan, X., He, X., Xiao, H., & Li, Y. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12792 · Cited by 32
Al-Rawashdeh, A., Kasabri, V. N., Bulatova, N., Akour, A. A., Zayed, A. A., Momani, M. S., Khawaja, N. M., Bustanji, H., & Hyassat, D. (2016) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2016.08.008 · Cited by 27
“Of note, serum betatrophin is elevated in diabetes and that levels are positively correlated with serum glucose [34].”
BackgroundResultYe, J., Qin, Y., Wang, D., Yang, L., & Yuan, G. (2019) · Disease Markers · doi:10.1155/2019/5096860 · Cited by 28
Zhang, L., Shannon, C. E., Bakewell, T. M., Abdul‐Ghani, M. A., Fourcaudot, M. J., & Norton, L. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00339.2019 · Cited by 29
Renal function is independently associated with circulating betatrophin
Maurer, L., Schwarz, F., Fischer‐Rosinsky, A., Schlueter, N., Brachs, S., Möhlig, M., Pfeiffer, A. F. H., Mai, K., Spranger, J., & Bobbert, T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173197 · Cited by 26
Evidences for Expression and Location of ANGPTL8 in Human Adipose Tissue
Catalano-Iniesta, L. A., Sánchez‐Robledo, V., Osma, M. D. C. I., Albiñana, A. G., Carrero, S., Blanco, E. J., Carretero‐Hernández, M., Carretero, J., & García‐Barrado, M. J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020512 · Cited by 27
“We have considered that the C ‐ terminal fragments resulting from protein degradation could play some important biological functions, as suggested by Fu et al, 2014 [45].”
BackgroundHehl, L., Creasy, K. T., Vitali, C., Scorletti, E., Seeling, K. S., Vell, M. S., Rendel, M. D., Conlon, D., Vujković, M., Zandvakili, I., et al. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000427 · Cited by 25
Ejarque, M., Borlaug, M., Vilarrasa, N., Martinez-Perez, B., Llauradó, G., Megía, A., Helland, T., Gutiérrez, C., Serena, C., Folkestad, O. H., et al. (2017) · Translational research · doi:10.1016/j.trsl.2017.03.001 · Cited by 25
ANGPTL8 enhances insulin sensitivity by directly activating insulin-mediated AKT phosphorylation
Zhang, Z., Wu, H., Dai, L., Yuan, Y., Zhu, Y., Ma, Z., Ruan, X., & Guo, X. (2020) · Gene · doi:10.1016/j.gene.2020.144707 · Cited by 27
The Relationship between Betatrophin Levels in Blood and T2DM: A Systematic Review and Meta-Analysis
Yue, S., Wu, J., Zhang, J., Liu, L., & Chen, L. (2016) · Disease Markers · doi:10.1155/2016/9391837 · Cited by 27
“01 Fu [10] 2014 USA Serum ELISA 14 5560 ± 2731.”
InfluentialWang, H., Wu, T., Wu, T., Yang, G., Hu, W., Yang, M., Yang, M., Liu, D., Gu, H. F., Zhu, Z., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21852 · Cited by 25
“Our findings are consistent with two recent reports [7, 8] and further confirm that betatrophin is associated with IR.”
BackgroundResultInfluentialIncreased Level of Angiopoietin Like Proteins 4 and 8 in People With Sleep Apnea
Alterki, A., Abu‐Farha, M., Al‐Khairi, I., Cherian, P., Devarajan, S., Shyamsundar, A., Ali, S., Al‐Mulla, F., Tuomilehto, J., & Abubaker, J. A. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00651 · Cited by 26
Rejeki, P. S., Baskara, P. G., Herawati, L., Pranoto, A., Setiawan, H. K., Lesmana, R., & Halim, S. (2022) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2021-0393 · Cited by 26
Eroğlu, İ., İremli, B. G., İdilman, İ. S., Yüce, D., Lay, İ., Akata, D., & Erbas, T. A. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad490 · Cited by 26
Mohany, K. M., & Rugaie, O. A. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00498-0 · Cited by 26
Qu, Q., Zhao, D., Zhang, F., Bao, H., & Yang, Q. (2017) · Journal of International Medical Research · doi:10.1177/0300060516680441 · Cited by 23
Fadaei, R., Shateri, H., DiStefano, J. K., Moradi, N., Mohammadi, M. R., Emami, F., Aghajani, H., & Ziamajidi, N. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03725-7 · Cited by 23
Dong, Y., Li, W., & Yin, J. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2253468 · Cited by 27
“Moreover, ChREBP inhibits lipoprotein lipase and limits VLDL clearance, possibly by activating the expression of apolipoprotein (APOC3) and angiopoietin-like protein 8 (ANGPTL8), resulting in dyslipidemia (Fu et al. 2014; Mirtschink et al. 2018).”
Cannon, M. E., Duan, Q., Wu, Y., Zeynalzadeh, M., Xu, Z. Q., Kangas, A. J., Soininen, P., Ala‐Korpela, M., Civelek, M., Lusis, A. J., et al. (2017) · G3 Genes Genomes Genetics · doi:10.1534/g3.117.300088 · Cited by 29
Hu, H., Yuan, G., Wang, X., Jin, S. Y., Gao, Z., Zhou, T., Yin, W., Cai, R., Ye, X., & Wang, Z. (2018) · Endocrine Journal · doi:10.1507/endocrj.ej18-0191 · Cited by 26
Harada, M., Yamakawa, T., Kashiwagi, R., Ohira, A., Sugiyama, M., Sugiura, Y., Kondo, Y., & Terauchi, Y. (2021) · PLoS ONE · doi:10.1371/journal.pone.0255147 · Cited by 24
“However, some clinical reports have demonstrated that circulating ANGPTL8 levels in type 2 diabetes patients are elevated compared with those in non-diabetes individuals [23–26]; ANGPTL8 levels are also elevated in obese individuals [20, 22, 23, 25].”
BackgroundHolmannová, D., Borská, L., Andrýs, C., Borský, P., Kremláček, J., Hamáková, K., Řeháček, V., Málková, A., Švadláková, T., Palička, V., et al. (2020) · Journal of Immunology Research · doi:10.1155/2020/7352637 · Cited by 21
Cengiz, M., Özenirler, S., & Kocabıyık, M. (2015) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000502 · Cited by 22
Angiopoietin-like 8 (Angptl8) controls adipocyte lipolysis and phospholipid composition
Mysore, R., Liebisch, G., Zhou, Y., Olkkonen, V. M., & Haridas, P. A. N. (2017) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2017.05.002 · Cited by 21
“Most of the recent studies suggest that plasma ANGPTL8 levels are elevated in type 2 diabetes (T2D), insulin resistance or obesity (Abu-Farha et al., 2016; Chen et al., 2015; Fu et al., 2014).”
BackgroundHigh betatrophin in coronary patients protects from cardiovascular events
Leiherer, A., Ebner, J., Muendlein, A., Brandtner, E. M., Zach, C., Geiger, K. D., Fraunberger, P., & Drexel, H. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.11.011 · Cited by 21
The Rise and the Fall of Betatrophin/ANGPTL8 as an Inducer ofβ-Cell Proliferation
Abu‐Farha, M., Madhoun, A. S. A., & Abubaker, J. A. (2016) · Journal of Diabetes Research · doi:10.1155/2016/4860595 · Cited by 23
“Other studies showed that ANGPTL8 level was increased in T2D as well [64, 67, 68, 70].”
Relationship of Serum Betatrophin with Nonalcoholic Fatty Liver in a Chinese Population
Hu, W., Shao, X., Guo, D., Hao, H., Zhang, Y., Xia, M., Gong, Y., Zhou, H., Fan, Y.-Q., & Yu, W. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170758 · Cited by 20
Circulating Betatrophin Levels Are Associated with the Lipid Profile in Type 2 Diabetes
Ghasemi, H., Tavilani, H., Khodadadi, I., Saidijam, M., & Karimi, J. (2015) · Chonnam Medical Journal · doi:10.4068/cmj.2015.51.3.115 · Cited by 20
“trophin levels and an atherogenic lipid profile.(12,13) Indeed, betatrophin affects the lipid profile through the regulation of very low density lipoprotein (VLDI) secretion from the liver and the inhibition of lipoprotein lipase activity.”
BackgroundLiu, J., Yang, K., Xiao, W., Le, Y., Lang, S., Zhang, J., Wei, R., Yang, J., & Hong, T. (2018) · Peptides · doi:10.1016/j.peptides.2018.07.001 · Cited by 20
“Nutrition intake is a stimulator of ANGPTL8 expression [4,5,11,44,45].”
Adipose Insulin Resistance and Circulating Betatrophin Levels in Women with PCOS
He, Y., Hu, W., Yang, G., Guo, H., Liu, H., & Li, L. (2020) · BioMed Research International · doi:10.1155/2020/1253164 · Cited by 22
Genetic and Metabolic Determinants of Plasma Levels of ANGPTL8
Oldoni, F., Bass, K., Kozlitina, J., Hudson, H., Shihanian, L. M., Gusarova, V., Cohen, J. C., & Hobbs, H. H. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab120 · Cited by 21
Guo, C. Y., Zhao, Z., Deng, X., Chen, Z., Tu, Z., & Yuan, G. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej19-0263 · Cited by 20
“also observed an increase in ANGPTL8 level in type 2 diabetic patients [56].”
BackgroundBetatrophin and Insulin Resistance
Guo, Q., Cao, S., & Wang, X. (2022) · Metabolites · doi:10.3390/metabo12100925 · Cited by 20
“Furthermore, betatrophin secretion in humans and mice was demonstrated to be correlated with serum TG or verylow-density lipoprotein (VLDL) concentration [4,22].”
Background
Metadata
- Authors
- Fu, Z., Berhane, F., Fite, A., Seyoum, B., Abou-Samra, A. B., & Zhang, R.
- Affiliations
- Wayne State University (US)
- Corresponding author
- Zhang, Ren
- Venue
- Scientific Reports
- Published
- 2014-05-23
- Volume
- 4
- Issue
- 1
- Pages
- 5013-5013
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC5381405
- OpenAlex
- W2154364167
- Cited by
- 232
- References
- 22
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 13 · 2023: 13 · 2022: 16 · 2021: 17 · 2020: 25 · 2019: 18 · 2018: 22 · 2017: 31 · 2016: 32 · 2015: 24 · 2014: 7
- FWCI
- 23.66
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-sa
- creativecommons.org/licenses/by-nc-sa/3.0/ (tdm)
- creativecommons.org/licenses/by-nc-sa/3.0/ (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- Wayne State University (176412)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- betatrophin, type 2 diabetes, obesity, hepatokines, postprandial lipemia, body mass index, pancreatic beta-cell proliferation, lipid metabolism, serum biomarkers
- MeSH terms
- Angiopoietin-like Proteins, Angiopoietin-Like Protein 8, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Humans, Male, Middle Aged, Obesity, Prognosis, Biomarkers, Case-Control Studies, Peptide Hormones
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.